FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994789075> ?p ?o ?g. }

• W2994789075 endingPage "e033728" @default.
• W2994789075 startingPage "e033728" @default.
• W2994789075 abstract "Objective To investigate whether the prices of new anticancer drugs correlated with their relative benefit despite negotiation. Design Retrospective cross-sectional study correlating new anticancer drugs prices with clinical outcomes. Setting We did a retrospective cross-sectional study including all new anticancer drugs approved by the European Medicines Agency (EMA) (2010–2016) and reimbursed in Italy. Main outcome(s) and measure(s) Information on clinical outcomes—in terms of median overall survival (OS), median progression-free survival (PFS) and objective response rate (ORR)—was extracted from pivotal trials as reported in the European Public Assessment Reports available on the EMA website. Cost of a full course treatment was estimated on negotiated official and discounted prices. Regression coefficients β, their levels of significance p and the coefficients of determination R 2 were estimated adjusting by tumour type. Results Overall, 30 new anticancer drugs (with 35 indications) were available for analysis. Where data on OS were available, we observed no correlation between the improvement in median OS (in weeks) and negotiated price (R 2 =0.067, n=16 drugs for 17 indications). When the clinical outcomes were expressed as improvements in the median PFS or ORR, 25 drugs (29 indications) were available for the analysis, and again, there was no correlation with prices (R 2 =0.004 and 0.006, respectively). Conclusions and relevance Our results suggest that the prices of anticancer drugs in Italy do not reflect their therapeutic benefit. Drug price negotiations, which is mandatory by law in Italy, do not seem to ensure that prices correlate with clinical benefits provided by the cancer drugs. These results call for further efforts to establish the standard determinants of drug prices available at the time of negotiation. These findings need to be confirmed in other countries where price negotiations are in place. Moreover, further investigations may verify whether outcome data obtained after drug marketing would improve the correlation between prices and therapeutic benefit." @default.
• W2994789075 created "2019-12-26" @default.
• W2994789075 creator A5001539034 @default.
• W2994789075 creator A5002544231 @default.
• W2994789075 creator A5015740152 @default.
• W2994789075 creator A5033279700 @default.
• W2994789075 creator A5035977850 @default.
• W2994789075 creator A5036757572 @default.
• W2994789075 creator A5039807679 @default.
• W2994789075 creator A5056067048 @default.
• W2994789075 creator A5068196173 @default.
• W2994789075 creator A5077215884 @default.
• W2994789075 creator A5078877717 @default.
• W2994789075 date "2019-12-01" @default.
• W2994789075 modified "2023-09-25" @default.
• W2994789075 title "Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy" @default.
• W2994789075 cites W1548578164 @default.
• W2994789075 cites W1570249624 @default.
• W2994789075 cites W1810662963 @default.
• W2994789075 cites W1937020882 @default.
• W2994789075 cites W1988105978 @default.
• W2994789075 cites W1995827154 @default.
• W2994789075 cites W1996004925 @default.
• W2994789075 cites W2024438548 @default.
• W2994789075 cites W2027990636 @default.
• W2994789075 cites W2043962455 @default.
• W2994789075 cites W2060918723 @default.
• W2994789075 cites W2062092016 @default.
• W2994789075 cites W2093248569 @default.
• W2994789075 cites W2118764768 @default.
• W2994789075 cites W2119870271 @default.
• W2994789075 cites W2194735827 @default.
• W2994789075 cites W2266428300 @default.
• W2994789075 cites W2296355105 @default.
• W2994789075 cites W2340118301 @default.
• W2994789075 cites W2408273152 @default.
• W2994789075 cites W2513403311 @default.
• W2994789075 cites W2551811440 @default.
• W2994789075 cites W2554384121 @default.
• W2994789075 cites W2557227300 @default.
• W2994789075 cites W2566459362 @default.
• W2994789075 cites W2586144993 @default.
• W2994789075 cites W2609272592 @default.
• W2994789075 cites W2615117870 @default.
• W2994789075 cites W2621250710 @default.
• W2994789075 cites W2735308505 @default.
• W2994789075 cites W2735789192 @default.
• W2994789075 cites W2738734168 @default.
• W2994789075 cites W2761038984 @default.
• W2994789075 cites W2761198089 @default.
• W2994789075 cites W2763952675 @default.
• W2994789075 cites W2899353411 @default.
• W2994789075 cites W2907815516 @default.
• W2994789075 doi "https://doi.org/10.1136/bmjopen-2019-033728" @default.
• W2994789075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6924817" @default.
• W2994789075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31826897" @default.
• W2994789075 hasPublicationYear "2019" @default.
• W2994789075 type Work @default.
• W2994789075 sameAs 2994789075 @default.
• W2994789075 citedByCount "15" @default.
• W2994789075 countsByYear W29947890752020 @default.
• W2994789075 countsByYear W29947890752021 @default.
• W2994789075 countsByYear W29947890752022 @default.
• W2994789075 countsByYear W29947890752023 @default.
• W2994789075 crossrefType "journal-article" @default.
• W2994789075 hasAuthorship W2994789075A5001539034 @default.
• W2994789075 hasAuthorship W2994789075A5002544231 @default.
• W2994789075 hasAuthorship W2994789075A5015740152 @default.
• W2994789075 hasAuthorship W2994789075A5033279700 @default.
• W2994789075 hasAuthorship W2994789075A5035977850 @default.
• W2994789075 hasAuthorship W2994789075A5036757572 @default.
• W2994789075 hasAuthorship W2994789075A5039807679 @default.
• W2994789075 hasAuthorship W2994789075A5056067048 @default.
• W2994789075 hasAuthorship W2994789075A5068196173 @default.
• W2994789075 hasAuthorship W2994789075A5077215884 @default.
• W2994789075 hasAuthorship W2994789075A5078877717 @default.
• W2994789075 hasBestOaLocation W29947890751 @default.
• W2994789075 hasConcept C100001284 @default.
• W2994789075 hasConcept C126322002 @default.
• W2994789075 hasConcept C142052008 @default.
• W2994789075 hasConcept C142724271 @default.
• W2994789075 hasConcept C143998085 @default.
• W2994789075 hasConcept C162324750 @default.
• W2994789075 hasConcept C167135981 @default.
• W2994789075 hasConcept C2780035454 @default.
• W2994789075 hasConcept C2910862244 @default.
• W2994789075 hasConcept C3018146709 @default.
• W2994789075 hasConcept C71924100 @default.
• W2994789075 hasConcept C98274493 @default.
• W2994789075 hasConceptScore W2994789075C100001284 @default.
• W2994789075 hasConceptScore W2994789075C126322002 @default.
• W2994789075 hasConceptScore W2994789075C142052008 @default.
• W2994789075 hasConceptScore W2994789075C142724271 @default.
• W2994789075 hasConceptScore W2994789075C143998085 @default.
• W2994789075 hasConceptScore W2994789075C162324750 @default.
• W2994789075 hasConceptScore W2994789075C167135981 @default.
• W2994789075 hasConceptScore W2994789075C2780035454 @default.
• W2994789075 hasConceptScore W2994789075C2910862244 @default.

• next